The driving force of the foundation is Dr. Josep Baselga, Professor of Medicine at the Autonomous University of Barcelona and former President of the European Society of Medical Oncology (ESMO). He is currently the Chairman of the Scientific Committee of the Vhio (Vall D'Hebron Institute of Oncology) Foundation.
Dr. Baselga began his professional career in the United States. First he worked at the State University of New York and from 1989 to 1994 at the Memorial Sloan-Kettering Cancer Center, one of the most prestigious cancer research centers in the world.
In 1996 he returned to Spain and joined the Vall d'Hebrón University Hospital where he was appointed Head of the Oncology Service and Director of the Oncology, Haematology and Radiation Therapy Department. In 2001 he created the Fero Oncology Research Foundation, a project inspired by the American model of philanthropy that seeks to involve Spanish civil society in the fight against cancer. Dr. Baselga was also president of the European Society of Medical Oncology (ESMO) during the period 2008-2009.
Dr. Baselga is, in addition, an associate editor of the Annals of Oncology and a member of the editorial board of Cancer Cell, Clinical Cancer Research, Journal of Clinical Oncology and Annals of Oncology. He has published more than 180 studies in specialized journals, as well as close to 300 articles and book chapters. Since 2013, he is Physician in Chief and Chief Medical Officer of the Memorial Hospital in New York. From 2015 to 2016, he was president of the American Association for Cancer Research (AACR).
Until December 2012, Dr. Baselga worked at the MGH, where he held the positions of Head of the Haematology and Oncology Unit and Deputy Director of the Cancer Center. In January 2013, he began working at the Memorial Sloan-Kettering Cancer Center in New York, a hospital considered the best cancer centre in the world.
Dr. Baselga conducts the clinical and translational research of the hospital, combining his responsibilities with those as President of VHIO's Internal Scientific Committee in Barcelona.
At present, Dr. Baselga, founder of Fero, is also the Executive President of the Foundation. Fero supports the structure, projects and objectives of Vhio, Vall d'Hebron Institute of Oncology.